脑部放疗，上午比下午敏感许多！3 Y- h1 M" s. q+ U4 N; F6 W0 Q% s. C
) d+ N/ Y$ K; }4 M" D" r: N
! L% A7 `/ K6 t
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.- U* j3 ?' [; y! j3 T( w
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?# w2 l! s7 |( o. X7 h
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
$ C6 g# `- Z. T. j2 s. F6 G- |SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
3 F2 A/ @! V# Q7 K" p
+ \( M1 j( e/ G7 U- e% Q! E, E9 \* b4 aAbstract
2 D+ m6 s$ _% _; T1 {+ oBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time., k" q# G/ ~5 I7 R) I
; _8 _0 `9 D# X& o' _
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.0 ~, C$ u/ I/ r! _4 H' F* K
/ Q0 t) H' V; g+ \6 E; j7 _( xRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026)., a; d3 m9 ]% V1 B- e
4 }2 v: e" P1 Q' n3 KCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.; V- O9 o3 R( c# V
% ^( J6 O; \# k; s* K* a
|
1 t; p" j9 a+ Q7 \ a
显身卡
